Literature DB >> 16582597

EGFR-dependent downregulation of Bim in epithelial cells requires MAPK and PKC-delta activities.

Marlene R Quadros1, Sharon Connelly, Csaba Kari, Marc T Abrams, Eric Wickstrom, Ulrich Rodeck.   

Abstract

Activation of the epidermal growth factor receptor (EGFR) provides a measure of protection to immortalized epidermal keratinocytes (HaCaT cells) against apoptosis induced by diverse cellular stressors. This effect is due, in part, to sustained MAPK-dependent Bcl-xL expression. Here, we report a second EGFR/MAPK-dependent signaling event that protects HaCaT cells against apoptosis incurred during forced suspension culture (anoikis). This pathway targets Bim, a pro-apoptotic BH3-only Bcl-2 family member. Bim expression was functionally relevant to HaCaT cell survival as demonstrated by partial protection against anoikis provided by siRNA-induced Bim downregulation. Growth factor starvation of attached and suspended cells was associated with enhanced Bim expression whereas EGFR activation reduced Bim expression by inducing Bim phosphorylation and proteasomal degradation. EGFR-dependent Bim phosphorylation required MAPK activation. Furthermore, PKC-delta activity contributed to both MEK/MAPK phosphorylation and Bim phosphorylation as demonstrated using both pharmacological inhibitors of PKC-delta and siRNA-mediated PKC-delta knockdown. In addition to HaCaT cells, EGFR activation supported survival and induced Bim phosphorylation in several squamous carcinoma cell lines in a strictly MAPK-dependent fashion. These results establish that EGFR activation attenuates susceptibility of immortalized and malignant keratinocytes to apoptosis by post-translational control of Bim-EL expression through a pathway requiring PKC-delta and MEK/MAPK activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16582597     DOI: 10.4161/cbt.5.5.2567

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  11 in total

Review 1.  Illuminating the center: mechanisms regulating lumen formation and maintenance in mammary morphogenesis.

Authors:  Mauricio J Reginato; Senthil K Muthuswamy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

2.  Proapoptotic protein Bim attenuates estrogen-enhanced survival in lymphangioleiomyomatosis.

Authors:  Chenggang Li; Na Li; Xiaolei Liu; Erik Y Zhang; Yang Sun; Kouhei Masuda; Jing Li; Julia Sun; Tasha Morrison; Xiangke Li; Yuanguang Chen; Jiang Wang; Nagla A Karim; Yi Zhang; John Blenis; Mauricio J Reginato; Elizabeth P Henske; Jane J Yu
Journal:  JCI Insight       Date:  2016-11-17

3.  Protein kinase Cδ protects against bile acid apoptosis by suppressing proapoptotic JNK and BIM pathways in human and rat hepatocytes.

Authors:  Cynthia R L Webster; Andrea N Johnston; M Sawkat Anwer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-30       Impact factor: 4.052

4.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.

Authors:  Pushkar A Phadke; Kedar S Vaidya; Kevin T Nash; Douglas R Hurst; Danny R Welch
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

Review 5.  The emerging role of lapatinib in HER2-positive breast cancer.

Authors:  Alice Ulhoa-Cintra; Larisa Greenberg; Charles E Geyer
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

Review 6.  The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond.

Authors:  Fotini M Kouri; Samuel A Jensen; Alexander H Stegh
Journal:  ScientificWorldJournal       Date:  2012-02-14

7.  BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations.

Authors:  Daniel B Costa; Balázs Halmos; Amit Kumar; Susan T Schumer; Mark S Huberman; Titus J Boggon; Daniel G Tenen; Susumu Kobayashi
Journal:  PLoS Med       Date:  2007-10       Impact factor: 11.069

8.  PKCδ regulates integrin αVβ3 expression and transformed growth of K-ras dependent lung cancer cells.

Authors:  Jennifer M Symonds; Angela M Ohm; Aik-Choon Tan; Mary E Reyland
Journal:  Oncotarget       Date:  2016-04-05

9.  Identification and characterisation of lamprey protein kinase C delta-like gene.

Authors:  Yang Xu; Siwei Zhu; Huan Zhao; Qingwei Li
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

10.  Inhibition of Bcl-2 and Bcl-xL overcomes the resistance to the third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancer.

Authors:  Yingjie Lu; Dongliang Bian; Xuelin Zhang; Huibiao Zhang; Zhenghong Zhu
Journal:  Mol Med Rep       Date:  2020-11-17       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.